Covid vaccines

Thus, the United Kingdom government has signed two partnerships: one with Biontech to provide 10,000 patients access to personalized cancer treatments by 2030 and a 10-year investment with Moderna in an innovation and technology center with a capacity of up to 250 million vaccines. The stars were aligned.

During the pandemic, the United Kingdom detected clinical trials for several weeks. But before it took years to complete a clinical trial. What has changed?

It was really compelling because for many years we have believed that research is slow. It took 20 years to get medicine on the market. Unfortunately, most patients with cancer will succumb to the point where the medicine is on the market. We have shown to the world that this can be done in a year, if you modernize your process, start parts of the process in parallel and use digital tools.

Of course, opening a clinical trial during pandemic is not necessarily the same as a clinical cancer trial. But you had a breakthrough moment for the cancer vaccine project at an early stage.

There was an experience conducted by BionTech, called BNT122, of people with high -risk bowel cancer, which did not recruit very well around the world. So when we announced the start -ups for cancer vaccine, the UK Cancer Community uses this opportunity. We opened this test at the Birmingham University Hospital, which was the most surprising to me because it is not a leading center for the study of cancer vaccines.

We had to receive 10,000 patients enrolled in the study and we got there within three months. It was quite amazing. This just shows that since we are a single healthcare system, we can do this much faster than any other country.

The dominota began to fall very quickly to the back of this success: we opened a test for head and neck cancer in Liverpool, an esophageal and stomach cancer test in Dundee, and a lung cancer test in London. We started to create a community of people who all insist on starting a cancer vaccine tests as quickly as possible.

Several MRNA-based cancer vaccines are in clinical trials in the late-stage internationally, and currently the United Kingdom is conducting 15 cancer trials. When will we see the first approved MRNA cancer vaccine?

We have experience to stop skin cancer from returning after cutting it. It is now completed. We have too diverted as each of the trials we conducted and the test ended a year in front of the schedule. This is completely unheard of cancer tests because they usually work too long.

What will happen now is that in the next six to 12 months we will monitor people in the test and train if there is a difference between people who have taken the cancer vaccine and those who are not. We hope to have results by the end of the year or the beginning of 2026. If successful, we will come up with the first approved personalized MRNA vaccine, only within five years of the first licensed MRNA vaccine for Covid. This is quite impressive.

Hear Lennard Lee to talk Cable health On March 18 at Kings Place, London. Pick up tickets on Health.wired.comS